Axi-Cel: Clinical Trials

2 trials of Axi-Cel, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting, 1 unknown. 2 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Not yet recruiting 1, Unknown 1
Phase 22Not yet recruiting 1, Unknown 1

Follow Axi-Cel: new trials by email Literature Review of Axi-Cel trials Research Report on Axi-Cel

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Disulfiram for Preventing Treatment Complications in Patients Undergoing CAR T-cell Therapy for Relapsed or Refractory Diffuse Large B-cell Lymphoma
Axicabtagene Ciloleucel, Biospecimen Collection, Computed Tomography - Recurrent Diffuse Large B-Cell Lymphoma, Refractory Diffuse Large B-Cell Lymphoma
Phase 1 / Phase 2Not yet recruitingUniversity of Michigan Rogel Cancer Center122026-11-012026-11-12
Chidamide Bridging for CAR-T Therapy
Chidamide, Fludarabine and cyclophosphamide, Anti-CD19 CAR-T cells - Non Hodgkin's Lymphoma
Phase 1 / Phase 2UnknownChinese PLA General Hospital1202022-05-252024-03-06

Conditions studied

Lymphoma, Large B-Cell, Diffuse (1)  ·  Lymphoma, Non-Hodgkin (1)

Sponsors

Chinese PLA General Hospital (1)  ·  University of Michigan Rogel Cancer Center (1)

Countries

China (1)  ·  United States (1)

Top investigators

Marcus Geer (1)  ·  Weidong Han, Ph.D (1)